Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($) |
Oct. 31, 2020 |
Oct. 31, 2019 |
|---|---|---|
| Income Tax Disclosure [Abstract] | ||
| U.S. NOL carryforwards | $ 272,993 | $ 670,787 |
| Other | (39,103) | |
| Stock option compensation | 92,669 | |
| Foreign R&D refunds | 196,240 | |
| Total | $ 561,902 | $ 631,684 |
| X | ||||||||||
- Definition Foreign research and development refunds. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|